Related Experiment Videos
Cardiovascular effects of polycyclic antidepressants
Angiology
|October 1, 1986
Summary
Polycyclic antidepressants (PCAs) are well-tolerated in patients with primary depression. This study found no significant cardiovascular adverse reactions in patients receiving PCAs, indicating their safety for managing depression.
Area of Science:
- Cardiology
- Psychiatry
- Pharmacology
Background:
- Polycyclic antidepressants (PCAs) are commonly prescribed for primary depression.
- Cardiovascular effects of PCAs require careful evaluation in patients with depression.
Purpose of the Study:
- To assess cardiovascular manifestations in patients with primary depression treated with PCAs.
- To determine the safety profile of PCAs regarding cardiac function and rhythm.
Main Methods:
- 14 patients with primary depression receiving PCAs for ≥6 months were studied.
- Cardiovascular assessment included M-mode echocardiogram and 24-hour ambulatory electrocardiogram.
- Plasma PCA concentrations were monitored.
Main Results:
- No significant adverse cardiovascular reactions were observed in any patient.
- Left ventricular function remained within normal limits via echocardiogram.
- Electrocardiogram showed rare supraventricular ectopic beats in 8 patients and ventricular ectopic activity (Lown grade 1) in 4 patients.
Conclusions:
- Antidepressant therapy with PCAs in therapeutic doses is well-tolerated in healthy young patients with primary depression.
- PCAs do not appear to cause significant adverse cardiovascular reactions in this population.
- Further research may explore long-term cardiovascular effects and optimal therapeutic ranges.